Antigen-specific monoclonal antibodies isolated from B cells expressing constitutively active STAT5

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Scheeren, Ferenc A ^a,b   van Geelen, Caroline M M ^a   Yasuda, Etsuko ^a   Spits, Hergen ^a   Beaumont, Tim ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 21; MONOCLONAL ANTIBODY; STAT5 PROTEIN; TETANUS TOXIN; EPITOPE; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN DERIVATIVE;

ADULT; ANIMAL CELL; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL DIVISION; CELL IMMORTALIZATION; CELL ISOLATION; CELL MUTANT; CELL SURVIVAL; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; MEMORY CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SOMATIC HYPERMUTATION; TRANSCRIPTION INITIATION; TRANSCRIPTION TERMINATION; ANIMAL; B LYMPHOCYTE; CELL CLONE; CELL LINE; CELL SEPARATION; DRUG EFFECT; GENETICS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELL LINE; CELL SEPARATION; CLONE CELLS; EPITOPES; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGIC MEMORY; INTERLEUKINS; MICE; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; STAT5 TRANSCRIPTION FACTOR; TETANUS TOXIN;

EID: 79954454508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017189     Document Type: Article

References (44)

1. Keller MA, Stiehm ER, (2000) Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 13: 602-614.
2. Casadevall A, Dadachova E, Pirofski LA, (2004) Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2: 695-703.
3. Kohler G, Milstein C, (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495-497.
4. Riechmann L, Clark M, Waldmann H, Winter G, (1988) Reshaping human antibodies for therapy. Nature 332: 323-327.
5. McCafferty J, Griffiths AD, Winter G, Chiswell DJ, (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348: 552-554.
6. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, et al. (2003) Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377.
7. Yamamura K, Kudo A, Ebihara T, Kamino K, Araki K, et al. (1986) Cell-type-specific and regulated expression of a human gamma 1 heavy-chain immunoglobulin gene in transgenic mice. Proc Natl Acad Sci U S A 83: 2152-2156.
8. Lonberg N, (2005) Human antibodies from transgenic animals. Nat Biotechnol 23: 1117-1125.
9. Burton DR, Barbas CF 3rd, (1994) Human antibodies from combinatorial libraries. Adv Immunol 57: 191-280.
10. Steinitz M, Klein G, Koskimies S, Makel O, (1977) EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 269: 420-422.
11. Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, et al. (2004) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 10: 871-875.
12. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, et al. (2008) Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature.
13. Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, et al. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326: 285-289.
14. Shvarts A, Brummelkamp TR, Scheeren F, Koh E, Daley GQ, et al. (2002) A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. Genes Dev 16: 681-686.
15. Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, et al. (2010) Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med 16: 123-128.
16. Scheeren FA, Naspetti M, Diehl S, Schotte R, Nagasawa M, et al. (2005) STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression. Nat Immunol 6: 303-313.
17. Scheeren FA, Diehl SA, Smit LA, Beaumont T, Naspetti M, et al. (2008) IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood 111: 4706-4715.
18. Diehl SA, Schmidlin H, Nagasawa M, van Haren SD, Kwakkenbos MJ, et al. (2008) STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation. J Immunol 180: 4805-4815.
19. Kurata H, Lee HJ, O'Garra A, Arai N, (1999) Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677-688.
20. Tangye SG, Avery DT, Deenick EK, Hodgkin PD, (2003) Intrinsic differences in the proliferation of naive and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol 170: 686-694.
21. Wagner EF, Hleb M, Hanna N, Sharma S, (1998) A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation. J Immunol 161: 1123-1131.
22. Parrish-Novak J, Dillon SR, Nelson A, Hammond A, Sprecher C, et al. (2000) Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
23. Good KL, Bryant VL, Tangye SG, (2006) Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol 177: 5236-5247.
24. Ozaki K, Spolski R, Ettinger R, Kim HP, Wang G, et al. (2004) Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 173: 5361-5371.
25. Ettinger R, Sims GP, Fairhurst AM, Robbins R, da Silva YS, et al. (2005) IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J Immunol 175: 7867-7879.
26. Wezel ALv, Steenis Gv, Hannik CA, Kapsenberg JG, Hofman B, et al. (1979) Preparation and administration of inactivated vaccine against anterior acute poliomyelitis in the Netherlands. Ned Tijdschr Geneeskd 123: 466-474.
27. Leyendeckers H, Odendahl M, Lohndorf A, Irsch J, Spangfort M, et al. (1999) Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol 29: 1406-1417.
28. Ushmorov A, Ritz O, Hummel M, Leithauser F, Moller P, et al. (2004) Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood 104: 3326-3334.
29. Zhuang Y, Soriano P, Weintraub H, (1994) The helix-loop-helix gene E2A is required for B cell formation. Cell 79: 875-884.
30. Lin H, Grosschedl R, (1995) Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376: 263-267.
31. Bain G, Gruenwald S, Murre C, (1993) E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. Mol Cell Biol 13: 3522-3529.
32. Kuppers R, Rajewsky K, (1998) The origin of Hodgkin and Reed/Sternberg cells in Hodgkin's disease. Annu Rev Immunol 16: 471-493.
33. Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, et al. (2000) Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 95: 1443-1450.
34. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17: 51-62.
35. Turner CA Jr, Mack DH, Davis MM, (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77: 297-306.
36. Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, et al. (2010) IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 207: 353-363.
37. Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, et al. (2010) IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 207: 365-378.
38. Reljic R, Wagner SD, Peakman LJ, Fearon DT, (2000) Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6. J Exp Med 192: 1841-1848.
39. Fornek JL, Tygrett LT, Waldschmidt TJ, Poli V, Rickert RC, et al. (2006) Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. Blood 107: 1085-1091.
40. Leonard WJ, O'Shea JJ, (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16: 293-322.
41. Lischke A, Moriggl R, Brandlein S, Berchtold S, Kammer W, et al. (1998) The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain. J Biol Chem 273: 31222-31229.
42. Rolling C, Treton D, Pellegrini S, Galanaud P, Richard Y, (1996) IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett 393: 53-56.
43. Hendriksen CF, van den Gun JW, Kreeftenberg JG, (1989) The use of the Toxin Binding Inhibition (ToBI) test for the estimation of the potency of the diphtheria component of vaccines. J Biol Stand 17: 241-247.
44. Hendriksen CF, vd Gun JW, Nagel J, Kreeftenberg JG, (1988) The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand 16: 287-297.